Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
Public ClinicalTrials.gov record NCT00082381. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effect of AC2993 (Synthetic Exendin-4) Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
Study identification
- NCT ID
- NCT00082381
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 551 participants
Conditions and interventions
Conditions
Interventions
- Exenatide (AC2993) Drug
- Insulin glargine Drug
Drug
Eligibility (public fields only)
- Age range
- 30 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2003
- Primary completion
- Jun 30, 2008
- Completion
- Jun 30, 2008
- Last update posted
- Apr 6, 2015
2003 – 2008
United States locations
- U.S. sites
- 21
- U.S. states
- 15
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Radiant Research-San Diego | San Diego | California | 92108 | — |
| Dorothy L. and James E. Frank Diabetes Research Institute | San Mateo | California | 94401 | — |
| Internal Medicine Associates Department of Research | Fort Myers | Florida | 33901 | — |
| Jacksonville Center for Clinical Research | Jacksonville | Florida | 32216 | — |
| Baptist Diabetes Associates | Miami | Florida | 33176 | — |
| Metabolic Research Institute, Inc. | West Palm Beach | Florida | 33401 | — |
| Springfield Diabetes & Endocrine Center | Springfield | Illinois | 62704 | — |
| Frederick Primary Care Associates | Frederick | Maryland | 21702 | — |
| Radiant Research, Inc. | St Louis | Missouri | 63141 | — |
| Lovelace Scientific Resources, Inc. | Las Vegas | Nevada | 89102 | — |
| Diabetes, Endocrine & Nutrition | Hampton | New Hampshire | 03842 | — |
| Lovelace Scientific Resources | Albuquerque | New Mexico | 87108 | — |
| Great Lakes Medical Research | Westfield | New York | 14787 | — |
| DOCS, Beth Israel Medical Center | Yonkers | New York | 10710 | — |
| Piedmont Medical Research Associates | Winston-Salem | North Carolina | 27103 | — |
| Jon Shapiro, MD | Philadelphia | Pennsylvania | 19146 | — |
| Endocrinology Consultants of East Tennessee | Knoxville | Tennessee | 37909 | — |
| Israel Hartman, MD | Arlington | Texas | 76014 | — |
| Diabetes & Glandular Research Associates, P.A. | San Antonio | Texas | 78229 | — |
| Jack Wahlen, MD | Ogden | Utah | 84403 | — |
| Rainier Clinical Research Center, Inc. | Renton | Washington | 98055 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00082381, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 6, 2015 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00082381 live on ClinicalTrials.gov.